Cytokinetics shares owned by NJ State Employees Deferred Compensation Plan
Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by NJ State Employees Deferred Compensation Plan
from 13F filings
Historical chart of NJ State Employees Deferred Compensation Plan investment in Cytokinetics
Tip: Access up to 7 years of quarterly data
All positions including Cytokinetics held by NJ State Employees Deferred Compensation Plan consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cytokinetics by NJ State Employees Deferred Compensation Plan
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.3M | 16k | 83.49 |
| 2023-09-30 | $457k | 16k | 29.46 |
| 2023-06-30 | $506k | 16k | 32.62 |
| 2023-03-31 | $545k | 16k | 35.19 |
| 2022-12-31 | $344k | 7.5k | 45.82 |
| 2022-09-30 | $363k | 7.5k | 48.40 |
More positions owned by NJ State Employees Deferred Compensation Plan
View all positions for NJ State Employees Deferred Compensation Plan